17.09% -0.00253

Prophase Labs Inc (PRPH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Prophase Labs Inc Borsa (PRPH) Ultime notizie

Prophase Labs Inc (PRPH)

Prophase Labs Inc Borsa (PRPH) Ultime notizie

ProPhase Labs stock trades quietly as investors look to recent diagnostics performance - ad-hoc-news.de

ProPhase Labs Flags Going Concern Risk as Q2 Loss Widens - Minichart

ProPhase Labs, Inc. Q2 2026: Revenue $1.01M, EPS $(0.22) — 10-Q Summary - TradingView

ProPhase Labs (NASDAQ: PRPH) flags going‑concern risk as cash runs low - Stock Titan

ProPhase Labs, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

ProPhase Labs Delays Quarterly SEC Filing - TipRanks

ProPhase Labs (PRPH) cites auditor review delays for late Q2 2026 10-Q filing - Stock Titan

ProPhase Labs Secures Convertible Loan to Strengthen Liquidity - TipRanks

ProPhase Labs enters senior secured convertible loan agreement with J.J. Astor & Co for $2.09 million principal amount - Bitget

ProPhase Labs, Inc. Revenue Breakdown – OTC:PRPH - TradingView

ProPhase Units Strike Tentative Deal To Avert Ch. 7 Push - Law360

ProPhase Labs Restates Q1 2026 Financials: Key Changes and Impact Explained in Amended 10-Q/A - Minichart

ProPhase Labs (NASDAQ: PRPH) restates Q1 2026 and discloses going concern risk - Stock Titan

ProPhase Labs Inc updates its health portfolio as ProPhase Labs stock trades on Nasdaq - Ad-hoc-news.de

ProPhase Labs Inc explores growth opportunities in diagnostics and consumer health - Ad-hoc-news.de

ProPhase Labs (PRPH) Q1 2026 loss, equity deficit and going‑concern risk - Stock Titan

ProPhase Labs, Inc. (PRPH) Q1 2026 10-Q: Financials, Stock Info, and Key SEC Filing Details - minichart.com.sg

ProPhase Labs, Inc. 1Q 2026: Revenue $478K, EPS $(0.43) — 10-Q Summary - TradingView

ProPhase Labs (PRPH) flags going concern risk after Q1 2026 loss and heavy financing - Stock Titan

ProPhase Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

PRPH: Net loss widened to $5.4 million amid revenue decline and ongoing liquidity challenges - TradingView

Price to sales forward of ProPhase Labs, Inc. – OTC:PRPH - TradingView

Enterprise value to EBITDA forward of ProPhase Labs, Inc. – OTC:PRPH - TradingView

ProPhase Labs, Inc. Actuals & Estimates (OTC:PRPH) - TradingView

Prophase Labs Inc (PRPH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

ProPhase Labs StockLong-term business model and market position - AD HOC NEWS

Prophase Labs Inc (PRPH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Prophase Labs Inc (PRPH) Valuation: PE, PB & Fair Value Analysis - TradingKey

Prophase Labs Inc (PRPH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Prophase Labs Inc (PRPH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Prophase Labs Inc (PRPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

ProPhase Labs, Inc. 2025 Annual Report: Genomics, Biotech, Diagnostics, and Supplement Innovations Overview - Minichart

ProPhase Labs, Inc. FY 2025: Revenue $4.35M, EPS ($1.74) — 10-K Summary - TradingView

[10-K] ProPhase Labs, Inc. Files Annual Report - Stock Titan

ProPhase Labs, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com

MSN Money - MSN

PRPH | PROPHASE LABS INC Insider Trading - Quiver Quantitative

ProPhase Labs stock (US74345W1080): earnings update and shifting focus beyond COVID testing - AD HOC NEWS

ProPhase Labs Delays Quarterly Financial Filing - TipRanks

ProPhase Labs (NASDAQ: PRPH) delays Q1 2026 10-Q amid 2025 audit - Stock Titan

ProPhase Labs stock (US74345W1080): Reverse stock split raises questions - AD HOC NEWS

TradingKey - TradingKey

Prophase Labs Stock Price Forecast. Should You Buy PRPH? - StockInvest.us

ProPhase Testing Units Creditor Says No Real Ch. 11 Progress - Law360

PROPHASE LABS INC by ProPhase Labs, Inc. Analyst Ratings and Price Targets | OTC:PRPH - Benzinga

ProPhase Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

ProPhase Labs earnings missed by $2.47, revenue fell short of estimates - Investing.com Canada

ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform - The Manila Times

Geopolitics Watch: What analysts say about ProPhase Labs Inc stock2026 Gainers & Target Return Focused Stock Picks - baoquankhu1.vn

ETF Watch: Is ProPhase Labs Inc exposed to political riskMarket Movement Recap & Weekly Stock Breakout Alerts - baoquankhu1.vn

Street Watch: Is ProPhase Labs Inc exposed to currency risksRate Cut & Daily Profit Focused Stock Screening - baoquankhu1.vn

Earnings Update: How much upside does ProPhase Labs Inc have2026 Recap & Stepwise Swing Trade Plans - baoquankhu1.vn

Will ProPhase Labs Inc outperform the market in YEARTrade Performance Summary & Safe Entry Point Alerts - baoquankhu1.vn

Nasdaq Moves: Will ProPhase Labs Inc benefit from AI trends2026 Investor Takeaways & Community Shared Stock Ideas - baoquankhu1.vn

Market Review: Whats next for ProPhase Labs Inc stock2026 Big Picture & Growth Oriented Trading Recommendations - baoquankhu1.vn

Simile a PRPH